Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cell-Free DNA Variables including Gene Mutations in CA15-3 Normal Breast Cancer Reflect Prognosis.

Disease markers - 1 Jan 2022

Xu Juan, Chen Wenxiu, Sun Ziwei, Peng Hailin, Zhou Chenglin, Pan Shiyang

Abstract excerpt

BACKGROUND: Cell-free DNA (cfDNA) has attracted considerable attention in precision medicine. However, few data are available regarding to the prognostic value of cfDNA variables in CA15-3 normal breast cancer (BC) patients. Here, we aimed at investigating the prognostic value of cfDNA variables including gene mutations in CA15-3 normal BC patients. METHODS: A total of 68 BC patients with normal CA15-3 levels...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms
Share to Cell-Free Nucleic Acids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Mucin-1

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 35251373
DOI: 10.1155/2022/5470166
PMCID: PMC8894049

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cell-Free DNA Variables including Gene Mutations in CA15-3 Normal Breast Cancer Reflect Prognosis.PMID 35251373Read ↗

Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancerSemantic proximity Read ↗

Multimodal analysis of cell-free DNA enhances differentiation of early-stage breast cancer from benign lesions and healthy individualsSemantic proximity Read ↗

Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer.Semantic proximity Read ↗

Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients.Semantic proximity Read ↗

Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancerSemantic proximity Read ↗

High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival.Semantic proximity Read ↗

Evaluation of cfDNA as an early detection assay for dense tissue breast cancer.Semantic proximity Read ↗

Discovery and validation of cell-free DNA methylation markers for specific diagnosis, differentiation from benign tumors, and prognosis of breast cancerSemantic proximity Read ↗

Circulating cell-free DNA-based epigenetic assay can detect early breast cancerSemantic proximity Read ↗

Detection of genomic alterations in breast cancer with circulating tumour DNA sequencingSemantic proximity Read ↗

Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients.Semantic proximity Read ↗

Detection of genomic alterations in breast cancer with circulating tumour DNA sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.